FDA Panel Urges Cautions With Skin-Cancer-Detecting Tools

A federal advisory panel offered a bevy of suggestions about how the FDA might proceed with potential future clearances for the broad use of tools intended to analyze skin lesions for cancer risk.

Related Keywords

New York ,United States ,Australia ,Memorial Sloan Kettering Cancer Center ,Northwestern University ,Illinois ,Netherlands ,United Kingdom ,California ,Maryland ,Chicago ,San Francisco ,Veronica Rotemberg ,Binita Ashar ,Paulae Bourelly ,Scibase Nevisense ,Deneen Hesser ,Hobartw Harris ,Murad Alam ,University Of California ,Radiological Health ,Drug Administration ,Northwestern University Feinberg School Of Medicine ,Devices Advisory Committee ,Mela Science Melafind ,New York City ,Feinberg School ,False Positives ,